Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect

Area of Science:

• Biomaterials Science
• Oncology
• Regenerative Medicine

Background:

• Hydroxyapatite (HA) is a key material for bone repair due to its biocompatibility.
• Emerging research indicates that HA nanoparticles (n-HA) possess anti-cancer properties.
• The potential of n-HA as a dual-action agent for bone regeneration and tumor suppression requires investigation.

Purpose of the Study:

• To evaluate the translational potential of n-HA as both a bone-regenerating material and an antitumor agent.
• To assess the efficacy of n-HA in inhibiting tumor growth, preventing metastasis, and improving survival rates.
• To investigate the mechanisms underlying n-HA's antitumor effects and its impact on bone regeneration in a tumor model.

Main Methods:

• Administered n-HA to tumor-bearing rabbits to assess antitumor effects and survival.
• Investigated n-HA's mechanism of action, including apoptosis induction and immune response.
• Fabricated and implanted a porous titanium scaffold loaded with n-HA into rabbit bone defects within a tumor model.

Main Results:

• n-HA treatment inhibited tumor growth, prevented metastasis, and enhanced survival rates in rabbits.
• In vivo studies confirmed activation of mitochondrial-dependent apoptosis and a stimulated immune response.
• The n-HA-loaded titanium scaffold effectively suppressed tumor growth and osteolytic lesions while promoting bone regeneration.

Conclusions:

• n-HA demonstrates significant potential as a dual-function therapeutic agent for bone defects associated with tumors.
• The findings support the use of n-HA in combination with orthopedic implants for treating tumor-related bone defects.
• n-HA offers a promising strategy for addressing the complex challenges of bone regeneration and cancer treatment in affected areas.